TLR ligands stimulation protects MSC from NK killing

Area of Science:

• Immunology
• Cell Biology
• Regenerative Medicine

Background:

• Mesenchymal stem cells (MSCs) possess immunosuppressive properties crucial for managing allograft rejection and graft-versus-host disease.
• Toll-like receptors (TLRs) are increasingly recognized for their role in modulating MSC functions and immune responses.

Purpose of the Study:

• To investigate how TLR ligand stimulation affects the interaction between MSCs and natural killer (NK) cells.
• To determine if TLR priming alters MSC susceptibility to NK cell-mediated cytotoxicity and immunosuppressive capacity.

Main Methods:

• Adult bone marrow and embryonic MSCs were primed with various TLR ligands.
• The resistance of primed MSCs to IL-2-activated NK cell killing was assessed.
• Expression of Natural Killer group 2D (NKG2D) and DNAM-1 ligands on MSCs was analyzed.
• The impact of TLR priming on MSC-mediated suppression of NK cell activity was evaluated.

Main Results:

• TLR-primed MSCs exhibited increased resistance to NK-induced killing compared to unprimed MSCs.
• This protection was associated with the modulation of NKG2D ligands (MHC class I chain A and ULBP3) and DNAM-1 ligands on MSCs.
• TLR3-primed MSCs demonstrated enhanced suppressive functions against NK cells, whereas TLR4-primed MSCs did not.
• A notable heterogeneity was observed in the functional responses of MSC responders, despite relatively homogeneous phenotypes.

Conclusions:

• MSCs can adapt their immune behavior in inflammatory conditions, becoming less vulnerable to NK cell-mediated lysis.
• TLR3 priming can augment MSCs' ability to suppress NK cell activity, offering a potential therapeutic advantage.
• The observed heterogeneity in MSC responses highlights the importance of identifying and selecting highly responsive MSC populations for cell-based therapies to optimize efficacy.